ÂÜÀòÂÒÂ×

David Eaton is a Senior Global Clinical Operations Program Director specializing in haematology with over twenty years of experience in clinical development, particularly in oncology. They have spent six years in Global Clinical Study Management at a leading multinational biotechnology company, demonstrating a proven track record in leading cross-functional study teams on complex phase 2 and 3 studies. Previously, they were responsible for ensuring the quality of clinical trial conduct at one of Europe's largest phase I oncology trials units. David has also served as a Clinical Compliance Manager and Clinical Trial Coordinator Team Leader at The Institute of Cancer Research, where they managed teams and ensured trial quality. They earned a Bachelor's Degree in Biochemistry and Genetics from Lancaster University.